NovoCure Limited (NVCR) Financial Statements (2025 and earlier)

Company Profile

Business Address NO. 4 THE FORUM
ST. HELIER, JE2 4UF
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments951,186870,147910,616921,248940,815958,035
Cash and cash equivalents164,796453,763240,821154,860156,978185,963
Short-term investments786,390416,384669,795766,388783,837772,072
Restricted cash and investments3,6473,6001,7431,652516676
Receivables64,70365,09161,22165,13370,98874,830
Inventory, net of allowances, customer advances and progress billings40,44242,39138,15236,80633,02331,723
Inventory40,44242,39138,15236,80633,02331,723
Prepaid expense   6,784   
Other undisclosed current assets32,85821,47915,89323,16320,14823,730
Total current assets:1,092,8361,002,7081,034,4091,048,0021,065,4901,088,994
Noncurrent Assets
Operating lease, right-of-use asset29,07632,99434,83529,01426,27825,529
Property, plant and equipment66,47758,91751,47945,56441,15636,454
Other noncurrent assets12,06214,89914,02212,41614,57211,147
Other undisclosed noncurrent assets11,71911,91111,38411,35711,51912,216
Total noncurrent assets:119,334118,721111,72098,35193,52585,346
TOTAL ASSETS:1,212,1701,121,4291,146,1291,146,3531,159,0151,174,340
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities90,17184,316153,75779,66882,53681,469
Accounts payable90,17184,31694,39179,66882,53681,469
Accrued liabilities   59,366   
Deferred revenue15,60515,87016,224   
Debt      
Other undisclosed current liabilities63,40260,0449,13477,49367,55167,306
Total current liabilities:169,178160,230179,115157,161150,087148,775
Noncurrent Liabilities
Long-term debt and lease obligation653,470569,652568,822567,986567,150566,324
Long-term debt, excluding current maturities653,470569,652568,822567,986567,150566,324
Liabilities, other than long-term debt21,74925,62627,43822,12921,25521,952
Deferred revenue     8071,843
Other liabilities18181875119136
Operating lease, liability21,73125,60827,42022,05420,32919,973
Other undisclosed noncurrent liabilities6,0236,5668,2585,3734,8405,143
Total noncurrent liabilities:681,242601,844604,518595,488593,245593,419
Total liabilities:850,420762,074783,633752,649743,332742,194
Equity
Equity, attributable to parent361,750359,355362,496393,704415,683432,146
Additional paid in capital1,422,9031,387,7651,353,4681,334,1201,306,6031,266,358
Accumulated other comprehensive loss(3,515)(4,147)(5,469)(1,992)(1,981)(2,691)
Accumulated deficit(1,057,638)(1,024,263)(985,503)(938,424)(888,939)(831,521)
Total equity:361,750359,355362,496393,704415,683432,146
TOTAL LIABILITIES AND EQUITY:1,212,1701,121,4291,146,1291,146,3531,159,0151,174,340

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues150,356138,503133,784127,321126,051122,182
Cost of revenue(34,654)(33,689)(32,556)(32,092)(34,018)(29,614)
Gross profit:115,702104,814101,22895,22992,03392,568
Operating expenses(149,282)(146,334)(152,944)(153,474)(154,693)(152,817)
Operating loss:(33,580)(41,520)(51,716)(58,245)(62,660)(60,249)
Nonoperating income   46,036   
Other undisclosed loss from continuing operations before equity method investments, income taxes   (4,906)   
Loss from continuing operations before equity method investments, income taxes:(33,580)(41,520)(10,586)(58,245)(62,660)(60,249)
Other undisclosed income (loss) from continuing operations before income taxes10,8519,878(27,948)10,0238,7569,169
Loss from continuing operations before income taxes:(22,729)(31,642)(38,534)(48,222)(53,904)(51,080)
Income tax expense(10,646)(7,118)(8,545)(1,263)(3,514)(1,981)
Net loss available to common stockholders, diluted:(33,375)(38,760)(47,079)(49,485)(57,418)(53,061)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net loss:(33,375)(38,760)(47,079)(49,485)(57,418)(53,061)
Other comprehensive income (loss)6321,322 (11)710(258)
Other undisclosed comprehensive loss   (3,036)   
Comprehensive loss:(32,743)(37,438)(50,115)(49,496)(56,708)(53,319)
Other undisclosed comprehensive loss, net of tax, attributable to parent   (441)   
Comprehensive loss, net of tax, attributable to parent:(32,743)(37,438)(50,556)(49,496)(56,708)(53,319)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: